Polymicrogyria in a child with KCNMA1-related channelopathy.


Journal

Brain & development
ISSN: 1872-7131
Titre abrégé: Brain Dev
Pays: Netherlands
ID NLM: 7909235

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 09 03 2021
revised: 20 09 2021
accepted: 27 09 2021
pubmed: 23 10 2021
medline: 3 3 2022
entrez: 22 10 2021
Statut: ppublish

Résumé

Polymicrogyria is a malformation of cortical development with overfolding of the cerebral cortex and abnormal cortical layering. Polymicrogyria constitutes a heterogenous collection of neuroimaging features, neuropathological findings, and clinical associations, and is due to multiple underlying etiologies. In the last few years, some glutamate and sodium channelopathies have been associated with cortical brain malformations such as polymicrogyria. The potassium calcium-activated channel subfamily M alpha 1 (KCNMA1) gene encodes each of the four alpha-subunits that make up the large conductance calcium and voltage-activated potassium channel "Big K+". KCNMA1-related channelopathies are associated with various neurological abnormalities, including epilepsy, ataxia, paroxysmal dyskinesias, developmental delay and cognitive disorders. We report the observation of a patient who presented since the age of two months with drug-resistant epilepsy with severe developmental delay initially related to bilateral asymmetric frontal polymicrogyria. Later, exome sequencing revealed a de novo heterozygous variation in the KCNMA1 gene (c.112delG) considered pathogenic. This first case of polymicrogyria associated with KCNMA1-related channelopathy may expand the phenotypic spectrum of KCNMA1-related channelopathies and enrich the recently identified group of developmental channelopathies with polymicrogyria.

Identifiants

pubmed: 34674900
pii: S0387-7604(21)00182-0
doi: 10.1016/j.braindev.2021.09.009
pii:
doi:

Substances chimiques

KCNMA1 protein, human 0
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

173-177

Informations de copyright

Copyright © 2021 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Denis Graber (D)

Département de Médecine Infantile, Groupe Hospitalier Littoral Atlantique, Centre Hospitalier Saint-Louis, Rue du Dr Schweitzer, 17000 La Rochelle, France. Electronic address: denis.graber@ch-larochelle.fr.

Eri Imagawa (E)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: eri.imagawa@mssm.edu.

Noriko Miyake (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan. Electronic address: nmiyake@yokohama-cu.ac.jp.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan. Electronic address: naomat@yokohama-cu.ac.jp.

Satoko Miyatake (S)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan; Clinical Genetics Department, Yokohama City University Hospital, Yokohama, Kanagawa 236-0004, Japan. Electronic address: miyatake@yokohama-cu.ac.jp.

Marianne Graber (M)

UMR 7266 LIENSs, CNRS La Rochelle Université Bâtiment Marie Curie, Avenue Michel Crépeau, 17042 La Rochelle Cedex 1, France. Electronic address: mgraber@univ-lr.fr.

Bertrand Isidor (B)

Service de génétique médicale, Unité de Génétique clinique, CHU de Nantes, Hôtel Dieu, 1 place Alexis Ricordeau, 44093 Nantes, CEDEX 1, France. Electronic address: bertrand.isidor@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH